⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2696971 | 1.00 | — | — | |
| SCHEMBL818248 | 1.00 | — | — | |
| SCHEMBL5950880 | 1.00 | — | — | |
| SCHEMBL3927878 | 1.00 | — | — | |
| SCHEMBL19363012 | 1.00 | — | — | |
| SCHEMBL2466059 | 0.84 | LMNA (0.35) | — | |
| SCHEMBL2931003 | 0.84 | LMNA (0.35) | — | |
| SCHEMBL15858 | 0.84 | LMNA (0.40) | — | |
| SCHEMBL15630 | 0.84 | LMNA (0.40) | — | |
| SCHEMBL21698544 | 0.84 | LMNA (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4594520-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2025-08-06 | — | — | EP | claimed |
| CN-119916028-A | Marker related to progressive freezing syndrome and kit thereof | 厦门市迈理奥科技有限公司 | 2025-05-02 | — | — | CN | claimed |
| WO-2024069235-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2024-04-04 | — | — | WO | claimed |
| CN-116806263-A | Method for producing 2, 4-dihydroxybutyric acid or L-threonine using microbial metabolic pathway | 德累斯顿科技大学 | 2023-09-26 | — | — | CN | claimed |
| US-12447118-B2 | Hair treatment compositions | CONOPCO, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| CN-119916028-A | Marker related to progressive freezing syndrome and kit thereof | 厦门市迈理奥科技有限公司 | 2025-05-02 | — | — | CN | disclosed |
| EP-4281572-A1 | PROCESS FOR PREPARING 2,4-DIHYDROXYBUTYRATE OR L-THREONINE USING A MICROBIAL METABOLIC PATHWAY | Technische Universität Dresden (DE) | 2023-11-29 | — | — | EP | disclosed |
| CN-116806263-A | Method for producing 2, 4-dihydroxybutyric acid or L-threonine using microbial metabolic pathway | 德累斯顿科技大学 | 2023-09-26 | — | — | CN | disclosed |
| WO-2023158255-A1 | COMPOUND FOR ELECTROLYTE, COMPOUND FOR ELECTROLYTE ADDITIVE, ELECTROLYTE MATERIAL, ELECTROLYTE ADDITIVE, ELECTROLYTE FOR SECONDARY BATTERY, AND SECONDARY BATTERY | 주식회사 렉쎌 | 2023-08-24 | — | — | WO | disclosed |
| US-20230159929-A1 | MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF | ALIGOS THERAPEUTICS, INC. | 2023-05-25 | — | — | US | disclosed |
| US-20230159929-A1 | MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF | ALIGOS THERAPEUTICS, INC. | 2023-05-25 | — | — | US | disclosed |
| CN-110996886-B | Hair composition for wound treatment | 联合利华知识产权控股有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-20070185062-A1 | Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2007-08-09 | — | — | US | disclosed |
| US-20070185062-A1 | Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2007-08-09 | — | — | US | disclosed |
| EP-1750572-A2 | METHOD OF DETERMINING THE SYMPATHETIC TONE AND SYSTEM FOR MEASUREMENT THEREOF | Stressmeter A/S (DK) | 2007-02-14 | — | — | EP | disclosed |
| EP-1720890-A2 | PHOSPONATE NUCLEOSIDES USEFUL AS ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS, AND INTERMEDIATES FOR THEIR PRODUCTION | K.U.Leuven Research & Development (BE) | 2006-11-15 | — | — | EP | disclosed |
| US-20060111347-A1 | Substituted sulfones and methods of use | AMGEN INC. (US) | 2006-05-25 | — | — | US | disclosed |
| WO-2006041888-A2 | SUBSTITUTED ARYL OR HETEROARYLSULFONYLBUTANAMIDES FOR USE AS ANTI-INFLAMMATORY AGENTS | AMGEN INC. (US) | 2006-04-20 | — | — | WO | disclosed |
| WO-2005084529-A2 | METHOD OF DETERMINING THE SYMPATHETIC TONE AND SYSTEM FOR MEASUREMENT THEREOF | STRESSMETER A/S (DK) | 2005-09-15 | — | — | WO | disclosed |
| WO-2005085268-A2 | PHOSPONATE NUCLEOSIDES USEFUL AS ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS, AND INTERMEDIATES FOR THEIR PRODUCTION | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2005-09-15 | — | — | WO | disclosed |